期刊文献+

酰胺质子转移成像的临床应用及挑战 被引量:3

Clinical application and challenges of amide proton transfer imaging
下载PDF
导出
摘要 近年来,酰胺质子转移(Amide proton transfer,APT)成像作为一种新的MR成像方法 ,在临床应用中得到越来越多的关注。APT成像技术能够通过水信号变化探测体内游离蛋白质、多肽的酰胺质子与水质子的化学交换特征,可从分子水平上反映脑发育、脑肿瘤、中风、新生儿缺氧缺血脑病等组织内蛋白质及(或)p H的变化。目前APT成像除神经系统外,在多个系统中也得到应用。APT成像作为一种在体、无创、无需外源性对比剂的细胞分子水平MR成像技术,能够为临床提供更多的信息,会在今后的研究中得到进一步发展。 In recent years, amide proton transfer(APT) imaging, as a new modality of MR imaging, has attracted more and more attention in clinical applications. APT imaging can detect the exchange characteristics of amide protons in free proteins and peptides and water protons by means of water signal changes. APT imaging can reflect tumor, stroke, neonatal hypoxicischemic encephalopathy related to protein and pH at the molecular level. In addition to the nervous system, APT imaging has now been used in several other systems. APT imaging, as an in vivo, noninvasive, cellular and molecular level MR imaging modality without exogenous contrast agents, can provide more information for clinical studies and will be further developed in future studies.
作者 王晓明 郑阳
出处 《中国临床医学影像杂志》 北大核心 2017年第10期692-696,共5页 Journal of China Clinic Medical Imaging
基金 国家自然科学基金(No.30570541 30770632 81271631) 盛京医院自由研究者基金(No.2014-02)
关键词 中枢神经系统疾病 磁共振成像 Central nervous system diseases Magnetic resonance imaging
  • 相关文献

参考文献2

二级参考文献31

  • 1Xi Q, Zhao XH, Wang P J, Guo QH, Yan CG, He Y. Functional MRI study of mild Alzheimer's disease using amplitude of low frequency fluctuation analysis. Chin Med J 2(112;125:858-62.
  • 2Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Siddique MM, et al. Magnetization transfer ratio in Alzheimer disease: Comparison with volumetric measurements. AJNR Am J Neuroradiol 2007:28:965-70.
  • 3Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust W J, et aL Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impaimlent measured with arterial spin-labeling MR imaging: Initial experience. Radiology 2005;234:851-9.
  • 4Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, et al. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimoda] imaging investigation. Neuroimage Clin 2014;4:604-14.
  • 5Takahashi H, lshii K, Hosokawa C, Hyodo T, Kashiwagi N, Matsuki M, et aL Clinical application of 3D arterial spin-labeled brain perl'usion imaging for Alzheimer disease: Comparison with brain perfusion SPECT. AJNR Am J Neuroradiol 2014;35:906-11.
  • 6Yates PA, Sirisriro R, Villemagne VL, Farquharson S, Masters CL, Rowe CC, et aL Cerebral microhemorrhage and brain B-amyloid in aging and Alzheimer disease. Neurology 2011;77:48-54.
  • 7Clerx L, van Rossum IA, Burns L, Knol DL, Scheltens 13, Verhey F, et aL Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment. Neurobiol Aging 2013;34:2003-13.
  • 8Zhou J, Payen JF, Wilson DA, Traystman R J, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003;9:1085-90.
  • 9Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 2011:17:130-4.
  • 10Zhou J, Hong X, Zhao X, Gao JH, Yuan J. APT-weighted and NOE-weightcd image contrasts in glioma with different RF saturation powers based on magnetization transfer ratio asymmetry analyses. Magn Resort Med 2013;70:320-7.

共引文献31

同被引文献24

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部